CLOVIS ONCOLOGY INC (CLVSQ)
Institutional ownership reported to the SEC as of Q3 2023, across 19 quarters.
1
Reporting holders
$11.0K
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Coppell Advisory Solutions LLC | $11.0K | 229 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 1 | $11.0K | 229 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 2 | $2.7K | 36,795 | 1 | 0 | 0 | 0.0% |
| Q4 2022 | 8 | $16.6K | 318,461 | 1 | 1 | 1 | 0.1% |
| Q3 2022 | 98 | $50.1M | 35,744,660 | 10 | 22 | 39 | 15.0% |
| Q2 2022 | 112 | $98.3M | 42,237,492 | 16 | 20 | 51 | 22.6% |
| Q1 2022 | 148 | $120.9M | 55,328,499 | 20 | 51 | 36 | 7.6% |
| Q4 2021 | 155 | $194.3M | 66,707,453 | 27 | 50 | 40 | 6.9% |
| Q3 2021 | 155 | $293.6M | 61,445,675 | 18 | 56 | 36 | 6.7% |
| Q2 2021 | 168 | $367.8M | 55,162,379 | 27 | 65 | 30 | 13.0% |
| Q1 2021 | 168 | $424.6M | 50,072,107 | 40 | 42 | 44 | 12.5% |
| Q4 2020 | 160 | $321.3M | 55,409,724 | 25 | 49 | 43 | 17.2% |
| Q3 2020 | 170 | $352.6M | 50,740,588 | 27 | 53 | 42 | 16.1% |
| Q2 2020 | 162 | $385.6M | 46,176,906 | 36 | 58 | 39 | 14.4% |
| Q1 2020 | 160 | $311.2M | 33,981,853 | 34 | 36 | 43 | 29.3% |
| Q4 2019 | 164 | $597.7M | 35,036,819 | 40 | 33 | 53 | 38.9% |
| Q3 2019 | 161 | $252.7M | 51,023,714 | 24 | 65 | 34 | 20.6% |
| Q2 2019 | 172 | $866.3M | 51,837,903 | 25 | 72 | 36 | 11.1% |
| Q1 2019 | 194 | $1.3B | 49,880,063 | 43 | 57 | 53 | 6.9% |
| Q4 2018 | 167 | $1.1B | 53,978,594 | 3 | 4 | 1 | 8.5% |